Works matching IS 22113428 AND DT 2025 AND VI 48 AND IP 1


Results: 16
    1
    2
    3
    4

    Telomere transcripts act as tumor suppressor and are associated with favorable prognosis in colorectal cancer with low proliferating cell nuclear antigen expression.

    Published in:
    Cellular Oncology (2211-3428), 2025, v. 48, n. 1, p. 239, doi. 10.1007/s13402-024-00986-y
    By:
    • Kienzl, Philip;
    • Deloria, Abigail J.;
    • Hunjadi, Monika;
    • Hadolt, Juliane M.;
    • Haering, Max-Felix;
    • Bothien, Angrit;
    • Mejri, Doris;
    • Korkut-Demirbaş, Medina;
    • Sampl, Sandra;
    • Weber, Gerhard;
    • Pirker, Christine;
    • Laengle, Severin;
    • Braunschmid, Tamara;
    • Dragona, Eleni;
    • Marian, Brigitte;
    • Gagos, Sarantis;
    • Lu, Lingeng;
    • Henson, Jeremy D.;
    • Lau, Loretta M. S.;
    • Reddel, Roger R.
    Publication type:
    Article
    5

    Next-generation BCMA-targeted chimeric antigen receptor CARTemis-1: the impact of manufacturing procedure on CAR T-cell features.

    Published in:
    Cellular Oncology (2211-3428), 2025, v. 48, n. 1, p. 219, doi. 10.1007/s13402-024-00984-0
    By:
    • Sierro-Martínez, Belén;
    • Escamilla-Gómez, Virginia;
    • Pérez-Ortega, Laura;
    • Guijarro-Albaladejo, Beatriz;
    • Hernández-Díaz, Paola;
    • de la Rosa-Garrido, María;
    • Lara-Chica, Maribel;
    • Rodríguez-Gil, Alfonso;
    • Reguera-Ortega, Juan Luis;
    • Sanoja-Flores, Luzalba;
    • Arribas-Arribas, Blanca;
    • Montiel-Aguilera, Miguel Ángel;
    • Carmona, Gloria;
    • Robles, Maria Jose;
    • Caballero-Velázquez, Teresa;
    • Briones, Javier;
    • Einsele, Hermann;
    • Hudecek, Michael;
    • Pérez-Simón, Jose Antonio;
    • García-Guerrero, Estefanía
    Publication type:
    Article
    6

    Pre-existing cell subpopulations in primary prostate cancer tumors display surface fingerprints of docetaxel-resistant cells.

    Published in:
    Cellular Oncology (2211-3428), 2025, v. 48, n. 1, p. 205, doi. 10.1007/s13402-024-00982-2
    By:
    • Drápela, Stanislav;
    • Kvokačková, Barbora;
    • Slabáková, Eva;
    • Kotrbová, Anna;
    • Gömöryová, Kristína;
    • Fedr, Radek;
    • Kurfürstová, Daniela;
    • Eliáš, Martin;
    • Študent jr, Vladimír;
    • Lenčéšová, Frederika;
    • Ranjani, Ganji Sri;
    • Pospíchalová, Vendula;
    • Bryja, Vítězslav;
    • van Weerden, Wytske M.;
    • Puhr, Martin;
    • Culig, Zoran;
    • Bouchal, Jan;
    • Souček, Karel
    Publication type:
    Article
    7

    Loss of histone deubiquitinase Bap1 triggers anti-tumor immunity.

    Published in:
    Cellular Oncology (2211-3428), 2025, v. 48, n. 1, p. 183, doi. 10.1007/s13402-024-00978-y
    By:
    • Chang, Hong;
    • Li, Mingxia;
    • Zhang, Linlin;
    • Li, Meng;
    • Ong, Swee Hoe;
    • Zhang, Zhiwei;
    • Zheng, Jie;
    • Xu, Xiang;
    • Zhang, Yu;
    • Wang, Jing;
    • Liu, Xingjie;
    • Li, Kairui;
    • Luo, Yao;
    • Wang, Haiyun;
    • Miao, Zhichao;
    • Chen, Xi;
    • Zha, Jie;
    • Yu, Yong
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15

    ONECUT2 is a druggable driver of luminal to basal breast cancer plasticity.

    Published in:
    Cellular Oncology (2211-3428), 2025, v. 48, n. 1, p. 83, doi. 10.1007/s13402-024-00957-3
    By:
    • Zamora, Irene;
    • Gutiérrez, Mirian;
    • Pascual, Alex;
    • Pajares, María J.;
    • Barajas, Miguel;
    • Perez, Lillian M.;
    • You, Sungyong;
    • Knudsen, Beatrice S.;
    • Freeman, Michael R.;
    • Encío, Ignacio J.;
    • Rotinen, Mirja
    Publication type:
    Article
    16